Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

ClinicalTrials.gov ID: NCT01455896

Public ClinicalTrials.gov record NCT01455896. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 3:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center Study to Evaluate Cardiovascular Outcomes With ITCA 650 in Patients Treated With Standard of Care for Type 2 Diabetes

Study identification

NCT ID
NCT01455896
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Intarcia Therapeutics
Industry
Enrollment
4,156 participants

Conditions and interventions

Interventions

  • ITCA 650 Drug
  • ITCA placebo Other

Drug · Other

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2013
Primary completion
Feb 29, 2016
Completion
Feb 29, 2016
Last update posted
Jan 26, 2017

2013 – 2016

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Study Site Chandler Arizona 85224
Intarcia Therapeutics, Inc Hayward California 94545
Study Site Long Beach California 90806
Study Site Port Hueneme California 93041
Study SIte San Diego California 92114
Study Site Bradenton Florida 34208
Study Site New Port Richey Florida 34652
Study Site Palm Harbor Florida 34684
Study Site Chicago Illinois 60634
Study Site Avon Indiana 46123
Study Site Evansville Indiana 47714
Study Site Franklin Indiana 46131
Study Site Greenfield Indiana 46140
Study Site Muncie Indiana 47304
Study Site Newton Kansas 67114
Study Site Wichita Kansas 67205
Study Site Wichita Kansas 67207
Study Site Metaire Louisiana 70006
Study Site Rochester Michigan 48307
Study Site St Louis Missouri 63141
Study Site Billings Montana 59101
Study Site Las Vegas Nevada 89128
Not listed Las Vegas Nevada 89148
Study Site Winston-Salem North Carolina 27103
Study Site Cincinnati Ohio 45236
Study Site Columbus Ohio 43213
Study Site Franklin Ohio 45005
Study Site Pittsburgh Pennsylvania 15236
Study Site Uniontown Pennsylvania 15401
Study Site Greer South Carolina 29651
Study Site Austin Texas 78745
Not listed Dallas Texas 75230
Study Site Dallas Texas 75231
Study Site San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01455896, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2017 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01455896 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →